ASSOCIATION OF NEUROFILAMENT LIGHT CHAIN WITH THE ANTIDEPRESSANT EFFECTS OF LOW-DOSE KETAMINE INFUSION AMONG PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

被引：0
|
作者：
Wu, Hui-Ju [1 ]
Chen, Mu-Hong [1 ,2 ]
Lin, Wei-Chen [1 ]
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Hsinchu, Taiwan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2025年 / 28卷
关键词：
D O I：
10.1093/ijnp/pyae059.560
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
pyae059.56
引用
收藏
页码：i314 / i315
页数：2
相关论文
共 50 条
  • [41] Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Ruhe, Henricus G.
    Rot, Marije Ann Het
    Kamphuis, Jeanine
    de Boer, Marrit K.
    Schoevers, Robert A.
    BJPSYCH OPEN, 2021, 8 (01):
  • [42] Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion (vol 241, pg 1, 2018)
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Cheng, Chih-Ming
    Li, Cheng-Ta
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Su, Tung-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 274 : 1219 - 1219
  • [43] Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study
    Chen, Mu-Hong
    Li, Cheng-Ta
    Lin, Wei-Chen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Cheng, Chih-Ming
    Su, Tung-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 225 : 709 - 714
  • [44] Current Suicide Risk, but Not Lifetime History of Attempted Suicide, Predicts Treatment Response to Low-Dose Ketamine Infusion: Post Hoc Analysis of Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression
    Lin, Wei-Chen
    Su, Tung-Ping
    Li, Cheng-Ta
    Tsai, Shih-Jen
    Tu, Pei-Chi
    Bai, Ya-Mei
    Chen, Mu-Hong
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2024, 32 (01) : 84 - 89
  • [45] Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression
    Shih-Jen Tsai
    Chung-Feng Kao
    Tung-Ping Su
    Cheng-Ta Li
    Wei-Chen Lin
    Chen-Jee Hong
    Ya-Mei Bai
    Pei-Chi Tu
    Mu-Hong Chen
    CNS Drugs, 2023, 37 : 243 - 253
  • [46] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
  • [47] Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression
    Tsai, Shih-Jen
    Kao, Chung-Feng
    Su, Tung-Ping
    Li, Cheng-Ta
    Lin, Wei-Chen
    Hong, Chen-Jee
    Bai, Ya-Mei
    Tu, Pei-Chi
    Chen, Mu-Hong
    CNS DRUGS, 2023, 37 (03) : 243 - 253
  • [48] Treatment-resistant depression - Response to low-dose transdermal but not oral selegiline
    Morgan, Peter T.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 313 - 314
  • [49] Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Cheng, Chih-Ming
    Li, Cheng-Ta
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Su, Tung-Ping
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 251 : 162 - 169
  • [50] Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression
    Liu, Yusi
    Hu, Qiyun
    Xu, Sen
    Li, Wanwen
    Liu, Junyun
    Han, Liang
    Mao, Hui
    Cai, Fang
    Liu, Qiaoyan
    Zhu, Renlai
    Fang, Caiyun
    Lou, Yifei
    Wang, Zhenhua
    Yang, Huiling
    Wang, Wenyuan
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 347 : 437 - 444
12345